Economic evaluation of biomarker-based surveillance for Hepatocellular Carcinoma in Thai patients with Compensated Liver Cirrhosis
Bi-annual routine HCC surveillance is suggested to be cost-effective for the Thai healthcare system when used for patients with CLC. Among biomarker-based approaches, GAAD appears to be the most cost-effective and could maximize the benefits of HCC surveillance in high-risk patients.
Authors
- Nutcha Pinjaroen
- Pisit Tangkijvanich
- Kittiyod Poovorawan (ORCID: https://orcid.org/0000-0003-2690-2961)
- David Wastlund
- Fabian Mueller
- Rebecca Sim Shu Yu
- Wirichada Pan-Ngum
- Peng Lu
Institutions
- Ministry of Health (SG)
- Chulalongkorn University (TH)
- Mahidol University (TH)
- Mahidol Oxford Tropical Medicine Research Unit (TH)
- Adaptations Glassware Cooperative (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1371/journal.pone.0337913
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00